{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:40:09Z","timestamp":1746344409447,"version":"3.40.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Pompe disease or glycogen storage disease type II is a rare autosomal recessive disorder caused by a deficiency of the lysosomal enzyme a-glucosidase. Although enzyme replacement therapy (ERT) with 2 weekly intervals following was considered an effective treatment for Pompe disease in 2006, few patients can afford to receive treatment in China because of the high cost. This study aimed to examine the standard management of enzyme replacement therapy for late-onset Pompe disease among patients over the age of 14\u200ayears from a nursing perspective in order to assess operating procedures. ERT injection fluid dispensing and infusion procedures using different methods were analyzed and compared in 3 patients with advanced Pompe disease for forming standard operation procedures. In addition, the impact of different methods on time consumption was analyzed by 1-way analysis of variance. There were significant differences in time consumption between different dispensing and infusion methods. The time of dispensing and infusing the injection fluids using the cooperative method was 15.97 minutes shorter than that using the conventional method (95% CI: 4.51\u201327.43, <jats:italic toggle=\"yes\">P\u200a<\/jats:italic>=<jats:italic toggle=\"yes\">\u200a<\/jats:italic>.012); the time using the modified method was 20.93 minutes shorter than that using the conventional method (95% CI: 9.47\u201332.39, <jats:italic toggle=\"yes\">P\u200a<\/jats:italic>=<jats:italic toggle=\"yes\">\u200a<\/jats:italic>.012); and there was no significant difference between the cooperative and modified methods (<jats:italic toggle=\"yes\">P\u200a<\/jats:italic>=<jats:italic toggle=\"yes\">\u200a<\/jats:italic>.431). Enzyme replacement therapy entails frequent treatment and strict nursing requirements related to the intravenous infusion process. In this context, a standard operating procedure can be used to control nursing times and labor costs effectively while ensuring a safe and effective infusion process.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024276","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T13:55:20Z","timestamp":1611410120000},"page":"e24276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease"],"prefix":"10.1097","volume":"100","author":[{"given":"Shan","family":"Tang","sequence":"first","affiliation":[{"name":"School of Nursing, Shanxi Medical University"},{"name":"Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachu","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Nursing, Shanxi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxing","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binquan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Nursing, Shanxi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2008.09.001","article-title":"Improvement with ongoing enzyme replacement therapy in advanced late-onset pompe disease: a case study","volume":"95","author":"Case","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R2-20250504","first-page":"304","article-title":"Over idiopathische hypertrofie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"key":"R4-20250504","first-page":"3","article-title":"First treatment for Pompe disease","volume":"40","author":"Listed","year":"2006","journal-title":"FDA Consum"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ymgme.2014.02.015","article-title":"Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease-a long-term follow-up","volume":"112","author":"Andreassen","year":"2014","journal-title":"Mol Genet Metab"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neurol.2013.07.002","article-title":"The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease","volume":"169","author":"Lafor\u00eat","year":"2013","journal-title":"Rev Neurol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0004-282X20150194","article-title":"Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease","volume":"74","author":"Llerena","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1468-1331.2008.02377.x","article-title":"Glycogen storage disease type II (Pompe disease)\u2013influence of enzyme replacement therapy in adults","volume":"16","author":"Merk","year":"2009","journal-title":"Eur J Neurol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2017.06.007","article-title":"Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme\u00ae) in 12 patients with advanced late-onset Pompe disease","volume":"122","author":"Papadopoulos","year":"2017","journal-title":"Mol Genet Metabol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clineuro.2010.09.016","article-title":"24-months results in two adults with Pompe disease on enzyme replacement therapy","volume":"113","author":"Vielhaber","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1017\/cjn.2016.37","article-title":"Pompe disease: diagnosis and management. Evidence-based guidelines from a Canadian expert panel","volume":"43","author":"Tarnopolsky","year":"2011","journal-title":"Can J Neurolog Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jpeds.2009.07.006","article-title":"The Brazilian consensus on the management of Pompe disease","volume":"155","author":"Llerena","year":"2009","journal-title":"J Pediatr"},{"key":"R13-20250504","article-title":"Infusion therapy in the older adult","author":"Fabian","year":"2010","journal-title":"Infusion Nursing: an Evidence-based Approach"},{"key":"R14-20250504","article-title":"Peripheral venous access devices","author":"Perucca","year":"2010","journal-title":"Infusion Nursing: an Evidence-based Approach"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.1007\/s10965-012-9915-4","article-title":"Temperature- and solvent-dependent migrations of di(2-ethylhexyl)phthalate, the hazardous plasticizer from commercial PVC blood storage bag","volume":"19","author":"Josh","year":"2012","journal-title":"J Polym Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/js9704700","article-title":"Short-term chronoamperometric screening of chlorpromazine-package interactions","volume":"87","author":"Sarsfield","year":"1998","journal-title":"J Pharm Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpainsymman.2005.09.008","article-title":"Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion","volume":"31","author":"Schneider","year":"2006","journal-title":"J Pain Symptom Manag"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.diabres.2008.02.013","article-title":"Adsorption of insulin onto infusion sets used in adult intensive care unit and neonatal care settings","volume":"80","author":"Zahid","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1590\/S0104-11692008000600005","article-title":"Standard operating procedure: use in nursing care in hospital services","volume":"16","author":"Guerrero","year":"2008","journal-title":"Rev Lat Am Enfermagem"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"NS61","DOI":"10.1097\/00005650-199211001-00006","article-title":"Results and impacts of the resource-based relative value scale","volume":"30","author":"Hsiao","year":"1992","journal-title":"Med Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:02:12Z","timestamp":1746342132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024276","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"2020-03-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}